Full Breakdown
Citizens Initiates Coverage of Fermi with Market Outperform Recommendation
2/10/2026, 1:19:10 PM
Overview of the Coverage Initiation
On February 9, 2026, Citizens initiated coverage of Fermi (NasdaqGS:FRMI) with a Market Outperform recommendation. This move comes as analysts project significant growth potential for Fermi, with an average one-year price target of $29.83 per share, indicating a potential upside of 243.66% from its latest closing price of $8.68 per share.
Analyst Projections and Market Sentiment
The price forecasts for Fermi range from a low of $20.20 to a high of $41.16, reflecting a strong bullish sentiment among analysts. The projected annual non-GAAP earnings per share (EPS) stands at 0.45. Additionally, the put/call ratio for Fermi is reported at 0.57, further suggesting a positive outlook among investors.
Institutional Ownership and Fund Sentiment
Fermi has seen a notable increase in institutional interest, with 47 funds or institutions reporting positions in the company. This marks a significant rise of 1,075% in ownership over the last quarter. Key institutional shareholders include Jefferies Financial Group, which holds 3,321,000 shares (0.53% ownership), UBS Group with 2,650,000 shares (0.42% ownership), and Empire Life Investments with 701,000 shares (0.11% ownership). Other notable investors include Geode Capital Management and Axxcess Wealth Management, holding 686,000 shares (0.11% ownership) and 76,000 shares (0.01% ownership), respectively.
Implications of the Coverage Initiation
The initiation of coverage by Citizens is expected to enhance Fermi's visibility in the market, potentially attracting more investors and driving up the stock price. The substantial projected upside and increasing institutional ownership may indicate growing confidence in Fermi's business model and future performance.
Criticism & Opposition
While the bullish outlook is prevalent, some analysts may express caution regarding the volatility of such projections, especially in the context of market fluctuations and economic uncertainties. Critics may argue that high price targets can lead to unrealistic expectations among investors.
Official Statements & Responses
Citizens has not released a detailed statement regarding the rationale behind its Market Outperform recommendation. However, the firm’s analysts are likely to emphasize Fermi's growth potential and market positioning as key factors influencing their decision.
